Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Assets (2017 - 2025)

Catheter Precision (VTAK) has disclosed Assets for 9 consecutive years, with $15.9 million as the latest value for Q4 2025.

  • Quarterly Assets fell 42.89% to $15.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $15.9 million through Dec 2025, down 42.89% year-over-year, with the annual reading at $15.9 million for FY2025, 42.89% down from the prior year.
  • Assets for Q4 2025 was $15.9 million at Catheter Precision, down from $25.5 million in the prior quarter.
  • The five-year high for Assets was $48.5 million in Q1 2023, with the low at $15.9 million in Q4 2025.
  • Average Assets over 5 years is $26.8 million, with a median of $26.3 million recorded in 2024.
  • The sharpest move saw Assets soared 104.27% in 2023, then plummeted 42.89% in 2025.
  • Over 5 years, Assets stood at $21.0 million in 2021, then dropped by 20.0% to $16.8 million in 2022, then surged by 82.56% to $30.7 million in 2023, then dropped by 9.65% to $27.8 million in 2024, then plummeted by 42.89% to $15.9 million in 2025.
  • According to Business Quant data, Assets over the past three periods came in at $15.9 million, $25.5 million, and $25.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.